Certican for Recipients of Kidney From HLA-identical Living Donors

Trial Profile

Certican for Recipients of Kidney From HLA-identical Living Donors

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Aug 2016

At a glance

  • Drugs Everolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Aug 2016 Status changed from active, no longer recruiting to completed.
    • 22 Mar 2015 Planned End Date changed from 1 Aug 2014 to 1 Aug 2015, according to to ClinicalTrials.gov record.
    • 22 Mar 2015 Planned primary completion date changed to 1 Aug 2014, according to to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top